Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
aerial, antitumor, bearing, bombardment, bulletin, cabinet, card, civilian, COD, CODM, confusion, deceptive, distinguishing, East, felony, fifteen, floor, FTC, Gaza, HCW, Hebrew, hERG, Hezbollah, Highlight, Houthi, HRSA, infiltrated, instruction, join, joining, KGaA, leadership, Lebanon, maker, MDP, MHMDA, Middle, NephroGenex, nonreciprocal, OCR, online, overcome, Palestinian, patching, placement, proactive, prostate, QT, regularly, RepliBiom, residing, rocket, Science, southern, spotlight, Strip, supersede, terror, terrorist, therewith, today, tranche, Trevena, twenty, undisclosed, unfair, unmutated, unregistered, unsecured, Wainright, war, Washington, West, widening, Windtree, Yemen
Removed:
aimed, bladder, capitalization, clarifying, classification, descending, excluding, exit, expedient, France, gastric, Gregory, intention, Korbel, lung, modified, mutual, NSCLC, optional, orderly, PCT, postpone, practical, ranged, reoccur, restarting, retrospective, revalue, routine, Taxpayer, temporarily
Filing tables
Filing exhibits
APRE similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements of Aprea Therapeutics, Inc. on Form S-3 (No. 333-276702) and Form S-8 (Nos. 333-234765, 333-250043, 333-260884, 333-265411, 333-268816 and 333-275440) of our report dated March 26, 2024, on our audit of the consolidated financial statements as of December 31, 2023 and for the year then ended, which report is included in this Annual Report on Form 10-K to be filed on or about March 26, 2024.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Philadelphia, Pennsylvania
March 26, 2024